Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CMPX
#3635
Compass Therapeutics, Inc. - Common Stock
0.9
4
USD
-0.05%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-5.05%
Monthly Change
-53.47%
6 month change
-81.89%
Year Change
-77.88%
Previous Close
0.9
9
Open
0.9
9
Low
0.9
2
High
0.9
9
Markets
US Stock Market
Healthcare
Biotechnology
CMPX
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
52.11 M
101.3 M
126.51 M
137.59 M
138.28 M
180.09 M
180.09 M
Valuation ratios
Enterprise value
—
176.62 M
616.57 M
179.4 M
157.03 M
936.43 M
139.77 M
Price to earnings ratio
—
—
13.81
4.42
4.03
-12.74
-2.33
Price to sales ratio
—
—
7 738.68
—
234.36
—
—
Price to cash flow ratio
—
—
15.87
4.63
4.44
-17.23
-3.04
Price to book ratio
—
—
2.98
1.27
1.59
4.3
0.22
Enterprise value to EBITDA ratio
—
-2.17
-15.12
-3.61
-2.8
-12.91
—
Profitability ratios
Return on assets %
-0.57
-0.53
-0.2
-0.27
-0.35
-0.3
-0.13
Return on equity %
-0.74
-0.59
-0.22
-0.29
-0.39
-0.34
-0.15
Return on invested capital %
-2 395.21
-4 286.45
-2 451.74
-3 972.63
-3 718.91
-2 705.51
—
Gross margin %
100
100
100
—
100
—
—
Operating margin %
9 932.86
-194.96 K
-59.51 K
—
-6 661.76
—
—
EBITDA margin %
9 175.71
-193.43 K
-58.26 K
—
-6 591.18
—
—
Net margin %
10.54 K
-195.67 K
-56.04 K
—
-5 808.82
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
4.97
13.84
12.05
19.73
14.96
15.02
11.22
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
-0.01
0
0
0
0.01
0
—
Solvency ratios
Debt to assets ratio
0.04
0
—
—
—
—
—
Debt to equity ratio
0.05
0
—
—
—
—
—
Long term debt to total assets ratio
-0
—
—
—
—
—
—
Long term debt to total equity ratio
-0
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-0.32
-0.32
-0.33
-0.31
-0.32
EBIT per share
—
—
-0.4
-0.4
-0.41
-0.46
—
EBITDA per share
—
—
-0.39
-0.39
-0.41
-0.46
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
1.77
1.2
0.92
1.32
0.96
Net current asset value per share
—
—
1.85
1.21
0.97
1.33
0.97
Tangible book value per share
—
—
1.73
1.17
0.91
1.25
0.89
Working capital per share
—
—
1.7
1.15
0.9
1.24
0.88
Book value per share
—
—
1.73
1.17
0.91
1.25
0.89
News
This Yum Brands Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Craig-Hallum Maintains Buy on Compass Therapeutics, Lowers Price Target to $8
This Autoliv Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Citizens Maintains Market Outperform on Compass Therapeutics, Lowers Price Target to $4
Guggenheim Maintains Buy on Compass Therapeutics, Lowers Price Target to $4
Wedbush Downgrades Compass Therapeutics to Neutral, Lowers Price Target to $1
HC Wainwright & Co. Maintains Buy on Compass Therapeutics, Lowers Price Target to $12
Crude Oil Down Over 1%; Thor Industries Shares Gain After Q4 Results
Compass Therapeutics Craters, FDA Pushes Survival-Trial Demand for Cancer Drug
12 Health Care Stocks Moving In Tuesday's Intraday Session
Dow Gains Over 100 Points; AutoZone Posts Upbeat Earnings
Compass Therapeutics: A 50% Price Cut Hiding A Regulatory Mispricing Opportunity